To make the list, CEOs must have led an S&P Global 1200 company for more than two years, without being convicted of a crime or arrested. That left 895 CEOs who were evaluated on both financial and nonfinancial performance. HBR scored each CEO on their financial performance using daily financial data, country-adjusted total shareholder return, industry-adjusted total shareholder return and change in market capitalization. They scored CEOs on environmental, social and governance using two firms that collect such data: Sustainalytics and CSRHub. The combined metrics filtered out 100 top CEOs.
Here are the 10 healthcare CEOs who made HBR‘s list this year.
- Lars Rebien Sørensen, Novo Nordisk (Denmark) — No. 1
- Michael Mussallem, Edwards Lifesciences (U.S.) — No. 20
- George Scangos, Biogen (U.S.) — No. 21
- Lars Rasmussen, Coloplast (Denmark) — No. 24
- Jean-Paul Clozel, Actelion (Switzerland) — No. 59
- Leonard Schleifer, Regneron Pharmaceuticals (U.S.) — No. 67
- Ken Thiry, DaVita (U.S.) — No. 82
- Haruo Naito, Eisai (Japan) — No. 87
- Christopher Rex, Ramsay Health Care (Australia) — No. 88
- Neil Patterson, Cerner (U.S.) — No. 90
Note: Larry Merlo, CEO of CVS Health, was ranked No. 60 on the list, but HBR put him in the retail category.
More articles on leadership and management:
Jonathan Gruber fires back at Trump over ACA criticism
Study suggests men in the boardroom still don’t value diversity
Sutter to cut 154 jobs under new staffing model: 3 things to know
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.